Kari Wilder-Romans - Concepedia

Author

Kari Wilder-Romans

University of Michigan ORCID

Also Known As

K Wilder-Romans, K. Wilder-Romans, Kari Wilder-Romans, Shuang (George) Zhao, Wilder-Romans, Kari

208

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Michigan Center for Translational Pathology Michigan Medicine Howard Hughes Medical Institute University of California, San Francisco

About

Kari Wilder-Romans is an author at University of Michigan specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	390
2	Engineering	1	1	83
3	Health Sciences	1	1	16
4	Natural Sciences	1	1	51
5	Biomolecular Engineering	1	1	945

Kari Wilder-Romans

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer Irfan A. Asangani, Vijaya L. Dommeti, Xiaoju Wang, Nature Radiation OncologyDrug TargetingAnti-cancer AgentTumor SuppressorProstatic Disease	2014	945
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression Yashar S. Niknafs, Sumin Han, Teng Ma, Nature Communications	2016	271
<i>PCAT-1</i> , a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer John R. Prensner, Wei Chen, Matthew K. Iyer, Cancer Research	2014	250
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma Weihua Zhou, Yangyang Yao, Andrew J. Scott, Nature Communications	2020	246
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer Irfan A. Asangani, Kari Wilder-Romans, Vijaya L. Dommeti, Molecular Cancer Research	2016	158
Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment Steven Kregel, Chao Wang, Xin Han, Neoplasia Androgen ReceptorChemoprevention StrategyPharmacotherapyProstate Cancer TreatmentTumor Biology	2020	137
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer Corey Speers, Shuang G. Zhao, Vishal Kothari, Clinical Cancer Research	2016	133
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis Daniel Wahl, Joseph Dresser, Kari Wilder-Romans, Cancer Research	2016	89
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination Benjamin C. Chandler, Leah Moubadder, Cassandra L. Ritter, Journal of Clinical Investigation Early RecurrenceSystems BiologyOncologyEngineeringRadiation Therapy	2020	83
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins Paradesi Naidu Gollavilli, Aishwarya Pawar, Kari Wilder-Romans, Cancer Research	2018	67

Page 1